Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Journal of Cancer Policy
|
May 16, 2024
Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis
Heba Altarawneh, Mohammad Manasrah, Yasemin Al Shanableh, et al.
JAMA Network Open
|
November 10, 2023
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
Mimi Najjar, John McCarron, Edward R Scheffer Cliff, et al.
Haematologica
|
February 5, 2026
Second primary malignancy in multiple myeloma: does a prior malignancy matter?
Alissa Visram, Hsien Seow, Rajeshkar Chakraborty, et al.
Journal of Cancer Policy
|
December 7, 2023
Use of subjective minimizing language at hematology and oncology conferences: A systematic review
Abdel-Azez Abusamak, Mohammad Abusamak, Mohammed Al-Abbadi, et al.
Archives of Pathology & Laboratory Medicine
|
July 2, 2024
Navigating the 2022 International Consensus and World Health Organization Classifications of Hematopathology: A Call for Unified Diagnostic Language
Hadil Zureigat, Bridget Adcock, Daniel P Nurse, et al.
Cancer
|
June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
Meera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Blood Cancer Journal
|
March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Hira Cheema, Asis Shrestha, Syed Naqvi, et al.
Blood Advances
|
July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging
Carolina Schinke, Leo Rasche, Cody Ashby, et al.
Journal of the National Cancer Institute
|
November 9, 2025
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
Maria Mainou, Muatassem Alsadhan, Kalliopi Tsapa, et al.
Clinical Hematology International
|
September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Tanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Journal of Cancer Policy
|
May 16, 2024
Authorship characteristics of hematology and oncology education chapters: A comprehensive analysis
Heba Altarawneh, Mohammad Manasrah, Yasemin Al Shanableh, et al.
JAMA Network Open
|
November 10, 2023
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
Mimi Najjar, John McCarron, Edward R Scheffer Cliff, et al.
Haematologica
|
February 5, 2026
Second primary malignancy in multiple myeloma: does a prior malignancy matter?
Alissa Visram, Hsien Seow, Rajeshkar Chakraborty, et al.
Journal of Cancer Policy
|
December 7, 2023
Use of subjective minimizing language at hematology and oncology conferences: A systematic review
Abdel-Azez Abusamak, Mohammad Abusamak, Mohammed Al-Abbadi, et al.
Archives of Pathology & Laboratory Medicine
|
July 2, 2024
Navigating the 2022 International Consensus and World Health Organization Classifications of Hematopathology: A Call for Unified Diagnostic Language
Hadil Zureigat, Bridget Adcock, Daniel P Nurse, et al.
Cancer
|
June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
Meera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Blood Cancer Journal
|
March 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients
Hira Cheema, Asis Shrestha, Syed Naqvi, et al.
Blood Advances
|
July 1, 2025
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging
Carolina Schinke, Leo Rasche, Cody Ashby, et al.
Journal of the National Cancer Institute
|
November 9, 2025
Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials
Maria Mainou, Muatassem Alsadhan, Kalliopi Tsapa, et al.
Clinical Hematology International
|
September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Tanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Page
of 10